CIAM
DAWN

Caitong International Asset Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Caitong International Asset Management’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$53.7K Buy
2,503
+2,200
+726% +$31K 0.01% 764
2025
Q4 		$2.82K Buy
+303
New +$2.53K ﹤0.01% 1289
2025
Q3 		– Sell
-918
Closed -$5.97K – 2061
2025
Q2 		$5.97K Buy
918
+875
+2,035% +$6.02K ﹤0.01% 947
2025
Q1 		$341 Buy
+43
New +$463 ﹤0.01% 1852

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Caitong International Asset Management's DAWN Position: Q1 2026 in Review

Caitong International Asset Management increased its Day One Biopharmaceuticals (DAWN) stake by 726% in Q1 2026, buying an estimated $31K and bringing the position to 2,503 shares worth $53.7K. The position accounts for 0.01% of the portfolio, ranked #764.

Caitong International Asset Management first reported a position in DAWN in Q1 2025 and has held it in 4 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Caitong International Asset Management held 2,503 shares of Day One Biopharmaceuticals worth $53.7K as of Q1 2026.
  • Caitong International Asset Management bought 2,200 Day One Biopharmaceuticals shares in Q1 2026, an estimated $31K.
  • Day One Biopharmaceuticals made up 0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #764 holding.
  • Caitong International Asset Management first reported a position in Day One Biopharmaceuticals in Q1 2025 and has held it in 4 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.